A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,753,013 shares of PBYI stock, worth $5.36 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,753,013
Previous 1,729,413 1.36%
Holding current value
$5.36 Million
Previous $9.17 Million 37.66%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$2.92 - $5.83 $68,912 - $137,588
23,600 Added 1.36%
1,753,013 $5.71 Million
Q1 2024

May 13, 2024

BUY
$4.29 - $7.4 $241,098 - $415,880
56,200 Added 3.36%
1,729,413 $9.17 Million
Q4 2023

Feb 13, 2024

SELL
$2.23 - $4.49 $119,057 - $239,716
-53,389 Reduced 3.09%
1,673,213 $7.25 Million
Q3 2023

Nov 14, 2023

SELL
$2.63 - $4.09 $82,610 - $128,470
-31,411 Reduced 1.79%
1,726,602 $4.54 Million
Q2 2023

Aug 11, 2023

SELL
$2.6 - $3.58 $199,940 - $275,302
-76,900 Reduced 4.19%
1,758,013 $6.21 Million
Q1 2023

May 12, 2023

BUY
$2.21 - $4.82 $300,714 - $655,857
136,070 Added 8.01%
1,834,913 $5.67 Million
Q4 2022

Feb 13, 2023

SELL
$2.12 - $5.08 $213,736 - $512,160
-100,819 Reduced 5.6%
1,698,843 $7.19 Million
Q3 2022

Nov 14, 2022

SELL
$2.27 - $3.84 $402,409 - $680,728
-177,273 Reduced 8.97%
1,799,662 $4.27 Million
Q2 2022

Aug 12, 2022

BUY
$1.64 - $3.3 $337,348 - $678,810
205,700 Added 11.61%
1,976,935 $5.63 Million
Q1 2022

May 13, 2022

SELL
$2.13 - $3.24 $105,696 - $160,778
-49,623 Reduced 2.73%
1,771,235 $5.1 Million
Q4 2021

Feb 11, 2022

BUY
$2.85 - $6.58 $538,430 - $1.24 Million
188,923 Added 11.58%
1,820,858 $5.54 Million
Q3 2021

Nov 12, 2021

BUY
$6.63 - $9.39 $222,768 - $315,504
33,600 Added 2.1%
1,631,935 $11.4 Million
Q2 2021

Aug 13, 2021

BUY
$8.98 - $11.6 $54,778 - $70,760
6,100 Added 0.38%
1,598,335 $14.7 Million
Q1 2021

May 13, 2021

SELL
$9.38 - $13.63 $649,096 - $943,196
-69,200 Reduced 4.17%
1,592,235 $15.5 Million
Q4 2020

Feb 10, 2021

BUY
$7.78 - $12.13 $853,761 - $1.33 Million
109,738 Added 7.07%
1,661,435 $17 Million
Q3 2020

Nov 13, 2020

BUY
$9.5 - $11.14 $817,000 - $958,040
86,000 Added 5.87%
1,551,697 $15.7 Million
Q2 2020

Aug 13, 2020

BUY
$7.01 - $13.24 $2.64 Million - $4.99 Million
377,100 Added 34.64%
1,465,697 $15.3 Million
Q1 2020

May 14, 2020

BUY
$6.28 - $14.57 $6.22 Million - $14.4 Million
991,097 Added 1016.51%
1,088,597 $9.19 Million
Q4 2019

Feb 13, 2020

BUY
$6.5 - $10.73 $633,750 - $1.05 Million
97,500 New
97,500 $853,000
Q3 2019

Nov 13, 2019

SELL
$8.75 - $12.85 $2.21 Million - $3.24 Million
-252,200 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$12.3 - $35.76 $1.97 Million - $5.73 Million
160,300 Added 174.43%
252,200 $3.21 Million
Q1 2019

May 14, 2019

SELL
$20.77 - $42.37 $3.86 Million - $7.87 Million
-185,700 Reduced 66.89%
91,900 $3.57 Million
Q4 2018

Feb 13, 2019

BUY
$20.07 - $46.7 $5.57 Million - $13 Million
277,600 New
277,600 $5.65 Million

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $139M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.